Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Prospective study of high-dose intravenous immunoglobulin for the treatment of steroid-resistant polymyositis and dermatomyositis.

Hara M, Kinoshita M, Saito E, Hashimoto H, Miyasaka N, Yoshida T, Ichikawa Y, Koike T, Ichikawa Y, Okada J, Kashiwazaki S.

Mod Rheumatol. 2003 Dec;13(4):319-25. doi: 10.3109/s10165-003-0250-9.

PMID:
24387253
2.

Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.

Cherin P, Piette JC, Wechsler B, Bletry O, Ziza JM, Laraki R, Godeau P, Herson S.

J Rheumatol. 1994 Jun;21(6):1092-7.

PMID:
7932419
3.

Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review.

Wang DX, Shu XM, Tian XL, Chen F, Zu N, Ma L, Wang GC.

Clin Rheumatol. 2012 May;31(5):801-6. doi: 10.1007/s10067-012-1940-5. Epub 2012 Jan 26. Review.

PMID:
22274797
4.

Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis.

Saito E, Koike T, Hashimoto H, Miyasaka N, Ikeda Y, Hara M, Yamada H, Yoshida T, Harigai M, Ichikawa Y.

Mod Rheumatol. 2008;18(1):34-44. doi: 10.1007/s10165-007-0013-0. Epub 2008 Jan 25. Erratum in: Mod Rheumatol. 2008;18(2):212.

PMID:
18217197
5.

Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.

Cherin P, Herson S, Wechsler B, Piette JC, Bletry O, Coutellier A, Ziza JM, Godeau P.

Am J Med. 1991 Aug;91(2):162-8.

PMID:
1714235
6.

Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients.

Cherin P, Pelletier S, Teixeira A, Laforet P, Genereau T, Simon A, Maisonobe T, Eymard B, Herson S.

Arthritis Rheum. 2002 Feb;46(2):467-74.

PMID:
11840450
7.

Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.

Barbasso Helmers S, Dastmalchi M, Alexanderson H, Nennesmo I, Esbjörnsson M, Lindvall B, Lundberg IE.

Ann Rheum Dis. 2007 Oct;66(10):1276-83. Epub 2007 Feb 2.

8.

Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.

Marie I, Menard JF, Hatron PY, Hachulla E, Mouthon L, Tiev K, Ducrotte P, Cherin P.

Arthritis Care Res (Hoboken). 2010 Dec;62(12):1748-55. doi: 10.1002/acr.20325.

9.

Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial.

Miyasaka N, Hara M, Koike T, Saito E, Yamada M, Tanaka Y; GB-0998 Study Group..

Mod Rheumatol. 2012 Jun;22(3):382-93. doi: 10.1007/s10165-011-0534-4. Epub 2011 Oct 5.

10.

Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study.

Shimojima Y, Ishii W, Matsuda M, Tazawa K, Ikeda S.

BMC Musculoskelet Disord. 2012 Nov 22;13:228. doi: 10.1186/1471-2474-13-228.

12.

Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis.

Suzuki Y, Hayakawa H, Miwa S, Shirai M, Fujii M, Gemma H, Suda T, Chida K.

Lung. 2009 May-Jun;187(3):201-6. doi: 10.1007/s00408-009-9146-6. Epub 2009 Apr 22.

PMID:
19387736
13.

Pandemic unadjuvanted influenza A (H1N1) vaccine in dermatomyositis and polymyositis: immunogenicity independent of therapy and no harmful effect in disease.

Shinjo SK, de Moraes JC, Levy-Neto M, Aikawa NE, de Medeiros Ribeiro AC, Schahin Saad CG, Precioso A, Silva CA, Bonfá E.

Vaccine. 2012 Dec 17;31(1):202-6. doi: 10.1016/j.vaccine.2012.10.063. Epub 2012 Oct 30.

14.
15.

Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.

Unger L, Kampf S, Lüthke K, Aringer M.

Rheumatology (Oxford). 2014 Sep;53(9):1630-8. doi: 10.1093/rheumatology/keu024. Epub 2014 Apr 4.

PMID:
24706995
16.

Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.

Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, Kita Y, Kawai M, Saito Y, Iwamoto I.

J Rheumatol. 1999 Jul;26(7):1527-33.

PMID:
10405940
17.

Intravenous immunoglobulin therapy for refractory myositis.

Moriguchi M, Suzuki T, Tateishi M, Hara M, Kashiwazaki S.

Intern Med. 1996 Aug;35(8):663-7.

18.

The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review.

Ge Y, Zhou H, Shi J, Ye B, Peng Q, Lu X, Wang G.

Clin Rheumatol. 2015 Dec;34(12):2097-103. doi: 10.1007/s10067-015-3065-0. Epub 2015 Sep 2. Review.

PMID:
26328518
19.

[A case of steroid-resistant polymyositis who made a good response to high dose intravenous immunoglobulins (IVIG)].

Saito M, Saito Y, Endo K, Tanaka M.

Rinsho Shinkeigaku. 2000 Feb;40(2):181-3. Japanese.

PMID:
10835943
20.

Effects of tacrolimus on dermatomyositis and polymyositis: a prospective, open, non-randomized study of nine patients and a review of the literature.

Matsubara S, Kondo K, Sugaya K, Miyamoto K.

Clin Rheumatol. 2012 Oct;31(10):1493-8. doi: 10.1007/s10067-012-2044-y. Epub 2012 Aug 12. Review.

PMID:
22886003

Supplemental Content

Support Center